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Abstract 23 
Dopamine D2 receptors (DRD2) have been strongly implicated in reward processing of natural 24 
stimuli and drugs. By using the Approach-Avoidance Task (AAT), we recently demonstrated 25 
that smokers show an increased approach bias toward smoking-related cues but not toward 26 
naturally-rewarding stimuli. Here we examined the contribution of the DRD2 Taq1B 27 
polymorphism to smokers’ and non-smokers’ responsivity toward smoking versus naturally-28 
rewarding stimuli in the AAT. Smokers carrying the minor B1 allele of the DRD2 Taq1B 29 
polymorphism showed reduced approach behavior for food-related pictures compared to non-30 
smokers with the same allele. In the group of smokers, a higher approach-bias toward smoking-31 
related compared to food-related pictures was found in carriers of the B1 allele. This pattern 32 
was not evident in smokers homozygous for the B2 allele. Additionally, smokers with the B1 33 
allele reported fewer attempts to quit smoking relative to smokers homozygous for the B2 allele. 34 
This is the first study demonstrating that behavioral shifts in response to smoking relative to 35 
natural rewards in smokers are mediated by the DRD2 Taq1B polymorphism. Our results 36 
indicate a reduced natural-reward brain reactivity in smokers with a genetically determined 37 
decrease in dopaminergic activity (i.e., reduction of DRD2 availability). It remains to be 38 
determined whether this pattern might be related to a different outcome after psychological 39 
cessation interventions, i.e. AAT modification paradigms, in smokers.   40 
 41 
Keywords: nicotine, smoking, approach-avoidance, dopamine D2 receptor, DRD2 Taq1B 42 
polymorphism  43 
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1. Introduction 44 
According to dual-process models, addictive behaviors occur as a consequence of an 45 
imbalance between a slowly operating reflective instance and a fast, approach-oriented or 46 
impulsive instance [1, 2]. The latter includes automatic approach biases toward drug-related 47 
cues which represent important triggers for both the initiation of drug intake and the “urge” to 48 
continue chronic drug use. In recent years, new paradigms have been developed for both the 49 
assessment and modification of such drug-cue induced automatic approach tendencies in the 50 
context of different addictions. The Approach-Avoidance Task (AAT) [3] has been used to 51 
measure existing approach biases in heroin [4], cannabis [5], alcohol [6] and nicotine addiction 52 
[7]. Likewise, several training versions of the AAT exist, which have been successfully 53 
employed to reduce approach biases toward addictive stimuli and to increase efficacy of 54 
conventional cessation interventions [8, 9] (for a review see: [2]).   55 
We have recently examined approach biases for smoking-related and naturally-56 
rewarding cues in smokers by means of the AAT [10]. We demonstrated that smoking is 57 
associated with a stronger approach bias for smoking-related pictures relative to naturally-58 
rewarding cues, in particular pictures of highly palatable food [10]. Although imaging studies 59 
already suggested a decrease in natural reward responsivity in the course of various addictions, 60 
our findings provide the first behavioral evidence for a shift in responsivity to drug cues at the 61 
expense of naturally-rewarding stimuli in smokers [11, 12]. Research on the functional 62 
significance and the underlying neuronal mechanisms mediating this shift in reward reactivity 63 
in addiction is still limited. However, it has been proposed that adaptations in meso-64 
corticolimbic dopamine signaling are likely to contribute to a decrease in motivational and 65 
behavioral responses to drugs and natural rewards in the course of an addiction [13-15]. For 66 
instance, a diminished activation of meso-striatal and meso-corticolimbic brain regions in 67 
response to natural reinforcers in detoxified cocaine addicts has been demonstrated [16]. 68 
Likewise, monetary rewards which activate typical dopaminergic regions including the striatum 69 
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and the prefrontal cortex in non-smokers are ineffective in activating the same reward circuits 70 
in smokers [17]. 71 
Since chronic drug use is accompanied with a progressive downregulation of dopamine 72 
D2 receptors (DRD2) in the meso-striatal brain regions [19, 20] and since DRD2 have been 73 
strongly implicated in the processing of naturally-rewarding stimuli and drugs [21], a decreased 74 
DRD2 density in addicts might account for the diminished responsivity toward natural rewards 75 
as a consequence of chronic substance use [19]. In this instance, it is well documented that 76 
polymorphisms of the DRD2 gene might represent susceptibility factors for various addictive 77 
phenotypes [21, 22]. The B1 allele of DRD2 Taq1B polymorphism in either heterozygosity or 78 
homozygosity is associated with less DRD2 density [23]. Subjects carrying the B1 allele exhibit 79 
an increased vulnerability to smoking [24, 25] and other addictive behaviors [26, 27] (for a 80 
review see: [28]) probably due to alterations in reward sensitivity [20]. With respect to 81 
processes related to smoking cessation in particular, a prominent role of the DRD2 Taq1B 82 
polymorphism has been confirmed [21, 22]. Compared to smokers homozygous for the B2 83 
allele, smokers with the minor B1 allele show fewer attempts to quit and stronger withdrawal 84 
symptoms after quitting smoking [29, 30], and are younger at the onset of smoking [24, 25, 31] 85 
which is inversely correlated to tobacco dependence [32] and to more difficulties to quit later 86 
in life [33].  87 
Given the important role of dopaminergic neurotransmission in reward processing of 88 
natural stimuli [16] and drugs [19] and the genetic modulation of DRD2 functionality in tobacco 89 
dependence [21, 22], we sought to determine whether the Taq1B polymorphism of the DRD2 90 
gene affects differences in smokers’ and non-smokers’ approach-avoidance biases toward 91 
smoking versus natural-reward stimuli in the AAT. To this end, we reanalyzed behavioral and 92 
self-report data from our previous study examining approach-avoidance tendencies in smokers 93 
and non-smokers [10]. We expected that depending on the smoking status, carriers of the B1 94 
allele and homozygous carriers of the B2 allele would show differences in responsivity toward 95 
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smoking-related and natural-reward stimuli in the AAT. Based on previous findings on the 96 
association between DRD2 Taq1B polymorphism and smoking behavior, a diminished 97 
approach-bias for natural rewarding cues in smokers carrying the B1 allele might be expected. 98 
Likewise, our previous finding on a stronger approach bias for smoking-related pictures relative 99 
to naturally-rewarding cues in smokers [10] should be mediated by the DRD2 Taq1B 100 
polymorphism and be more pronounced in smokers carrying the B1 allele.   101 
 102 
2. Material and Methods 103 
Self-report and behavioral measures obtained from participants in the Machulska et al. 104 
(2015) study were reanalyzed to examine the effect of the Taq1B polymorphism of the DRD2 105 
gene on these measures. All subjects were genotyped at the beginning of the study. The final 106 
sample comprised 90 smokers (mean age = 26.6; 44% female; mean Fagerström Test for 107 
Nicotine Dependence Score [FTND] = 3.4), and 49 non-smokers (mean age = 23.3; 59% 108 
female). Each participant provided written informed consent for the experimental procedure 109 
and the study was approved by the local Ethics Committee of the Ruhr-Universität Bochum. 110 
 111 
2.1 Self-report measures 112 
Each participant completed an extensive set of questionnaires concerning her/his: (i) 113 
Current smoking status, (ii) subjective cigarette craving (ranging from 0 (“not at all”) to 5 (“very 114 
high”)), (iii) degree of nicotine dependence (FTND with a score of 0 indicating no or very weak 115 
dependence and a score of 10 indicating very high nicotine dependence [34]; German version: 116 
[35]), (iv) attitude toward smoking (items ranging from -3 and +3; [36]) and (v) smoking 117 
abstinence motivation (Stages of Change Scale [37]; German version: [38]). For full description 118 
of all questionnaires see Machulska and colleagues [10].  119 
 120 
2.2 Automatic approach and avoidance tendencies 121 
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Automatic approach and avoidance tendencies were assessed with an adapted version 122 
of the Nicotine-Approach-Avoidance-Task (N-AAT). For a detailed task description see: [10]. 123 
Briefly, during the AAT, discrete pictures from four different categories were displayed on a 124 
computer screen: (a) smoking-related pictures, (b) shape- and color-matched pictures of tooth-125 
cleaning, (c) pictures of highly palatable food (e.g., pizza, ice cream, etc.) and (d) shape- and 126 
color-matched neutral pictures (i.e., empty dishes). Each picture was either rotated 3° to the left 127 
or 3° to the right. Participants were instructed to pull pictures rotated to the left and to push 128 
pictures rotated to the right, as quickly and accurately as possible by using a joystick which was 129 
connected to the computer. Upon a pull movement, picture size increased, whereas upon a push 130 
movement, picture size decreased, creating a zooming effect [3]. Each picture from the four 131 
picture categories was presented for a total of six times (three times in pull-closer format and 132 
three times in push-away format), resulting in 192 trials. 133 
 134 
2.3 Genotyping 135 
All participants were informed to refrain from eating food and drinking beverages apart 136 
from water approximately. 60 minutes prior to the study. DNA samples were collected using 137 
Oragene saliva kits (DNA Genotek, Ottawa, Canada). DNA extraction and genotyping was 138 
performed using established procedures according to the manufacturer’s protocol. The DRD2 139 
Taq1B polymorphism was genotyped by LGC Genomics (Hoddesdon, UK) using KASP 140 
technology with validated arrays. Five participants (all smokers) could not be genotyped, giving 141 
a total sample of 134 participants and a genotyping success rate of 96.4%.  142 
 143 
2.4 Data preparation and statistical analysis 144 
The Hardy-Weinberg exact test was used [https://www.cog-145 
genomics.org/software/stats] to analyze whether the genotype distribution is in Hardy-146 
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Weinberg equilibrium. Chi-square tests were used for the statistical analysis of allele 147 
frequencies and the distribution of genotypes in smokers and non-smokers. 148 
Genotype was defined using a dominant model: Homozygotes for the minor B1 allele 149 
(B1/B1) were grouped together with heterozygotes (B1/B2) and compared to homozygotes for 150 
the major B2 allele (B2/B2).  151 
Individual AAT bias scores were calculated for each participant. First, error trials were 152 
removed and AAT-bias scores were calculated by subtracting median reaction times (RTs) for 153 
pulling a picture from median RTs for pushing a picture for each of the four picture categories, 154 
separately (median RTpush – median RTpull; see: [10]). 155 
To examine whether the genotype contributed to differences in smokers’ and non-156 
smokers’ AAT bias scores, a 2 (genotype: B1 allele carriers versus B2 homozygotes) x 2 157 
(smoking status: smoker versus non-smoker) x 4 (picture category: nicotine-related versus 158 
tooth-cleaning versus food-related versus neutral pictures) mixed design ANOVA was 159 
conducted. Significant main effects and/or first-order (two-way) interactions were investigated 160 
with simple effect analyses. To investigate the second-order (three-way) interaction, two 161 
separate 2 x 4 ANOVAS were conducted with genotype removed and smoking status (smoker 162 
versus non-smoker) as the main between-subjects factor. To account for multiple testing, a more 163 
conservative level of significance was applied, using the Bonferroni correction for multiple (n) 164 
testing (pcorrected = puncorrected x n). Separate univariate ANOVAS were used to determine genetic 165 
influences on smokers’ smoking history and behavior, i.e. subjective craving, degree of nicotine 166 
dependence, motivation to quit smoking and attempts to quit smoking during the last 12 months. 167 
Again, Bonferroni correction was used to ensure that the cumulative Type I error was below α 168 
= .05.  Analyses were performed using IBM SPSS Statistics for Windows 23. 169 
 170 
 171 
 172 
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 173 
3. Results 174 
3.1 Genotyping 175 
Genotyping resulted in two subjects (both smokers) homozygous for the B1 allele, 39 176 
subjects with the heterozygous B1B2 genotype (26 smokers and 13 non-smokers), and 93 177 
subjects homozygous for the major B2 allele (57 smokers and 36 non-smokers). Allele 178 
frequencies were .15 for the B1 allele (for smokers .18, for non-smokers .13) and .84 for the B2 179 
allele (for smokers .82, for non-smokers .87), respectively. No significant differences in allele 180 
frequencies were found between smokers and non-smokers (ps > .33). No significant deviations 181 
from Hardy-Weinberg equilibrium were detected (p = 0.52). Sample characteristics according 182 
to smoking status and genotype are summarized in Table 1. 183 
 184 
3.2 Automatic approach and avoidance tendencies 185 
Mean AAT reaction times per genotype and smoking status for pulling versus pushing 186 
a picture are summarized in Table 2. To test the effect of the DRD2 Taq1B polymorphism on 187 
automatic approach-avoidance tendencies assessed with the AAT, a 2 x 2 x 4 mixed design 188 
ANOVA with smoking status (smoker vs. non-smoker) and genotype (B1 allele carriers vs. B2 189 
homozygotes) as between-subjects factors and picture category (nicotine-related vs. tooth-190 
cleaning vs. food-related vs. neutral pictures) as within-subjects factor was conducted. As 191 
published previously [10], there was a significant main effect of picture category, F(3, 128) = 192 
10.54, p < .001, η² = .2., and a significant picture category x smoking status interaction, F(3, 193 
128) = 5.29, p = .002, η² = .11. Furthermore, a significant picture category x genotype 194 
interaction was evident, F(3, 128) = 5, p = .003, η² = .11. Irrespective of smoking status, simple 195 
effect analyses indicated that B1 allele carriers showed a larger avoidance bias toward tooth-196 
cleaning pictures (M = -26, SD = 11) as compared to nicotine-related (M = 3, SD = 12; p = .05), 197 
neutral (M = 21, SD = 11; p < .001), and, by trend, food-related pictures (M = 1, SD = 10; p = 198 
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.075). Furthermore, B2 homozygotes showed a higher approach bias toward nicotine-related 199 
pictures (M = 24, SD = 8) relative to tooth-cleaning (M = -10, SD = 7; p < .001) and relative to 200 
neutral pictures (M = -2, SD = 7; p < .001). In addition, B2 homozygotes showed a larger 201 
approach bias toward food-related pictures (M = 11, SD = 6) relative to tooth-cleaning pictures 202 
(p = .01).  203 
Smoking status differentially affected the effect of genotype on AAT biases for the 204 
different picture categories, as the smoking status x DRD2 genotype x picture category 205 
interaction approached significance (F(3, 128) = 2.63, p = .053, η²  = .06). In order to obtain an 206 
accurate picture of the three-way interaction, we conducted two 2 x 4 ANOVAS for each 207 
genotype separately and with smoking status (smoker versus non-smoker) as the between 208 
subjects factor.  209 
For the B1 allele, Bonferroni corrected analyses revealed a main effect of picture 210 
category, F(3, 37) = 5.84, pcorrected = .004, η² = .32, qualified by a significant smoking status x 211 
picture category interaction, F(3, 37) = 4.95, pcorrected = .01, η² = .29. Specifically, on a between-212 
group level, simple effect analyses revealed that smokers carrying the B1 allele showed less 213 
approach for food images than non-smokers carrying the B1 allele (Msmokers+B1 =  -16, SD = 9, 214 
Mnon-smokers+B1 = 18, SD = 13, p = .03) (see Figure 1). No other between-group differences 215 
reached significance (for smoking pictures: p = .10, for tooth-cleaning pictures: p = .08, for 216 
neutral pictures: p = .62). Furthermore, on a within-group level, genotype affected approach 217 
biases in smokers in particular, evidenced by a decreased approach bias for food images (Mfood 218 
= -16, SD = 9) relative to nicotine-related pictures (Mnicotine = 20, SD = 12; p = .03) and relative 219 
to neutral pictures (Mneutral = 16, SD = 11; p = .02) in smokers carrying the B1 allele. 220 
Furthermore, non-smokers with the B1 allele expressed a stronger avoidance bias for tooth-221 
cleaning images relative to food images (Mtooth-cleaning = -45, SD = 18; Mfood = 18, SD = 13, p = 222 
.005) and relative to neutral images (Mneutral = 26, SD = 16, p = .002).  223 
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Finally, no group differences in response to the four picture categories occurred for B2 224 
homozygotes as evidenced by a non-significant interaction between smoking status and picture 225 
category (F(3, 89) < 1, pcorrected = .86, η² = .03). 226 
 227 
3.3 Self-report measures 228 
The DRD2 Taq1B polymorphism had no effect on craving or nicotine addiction severity 229 
(FTDN score) in smokers (see Table 1 for statistics; all pscorrected ≥ 0.20; separate one-way 230 
ANOVAs with genotype as the between-subjects factor). However, the DRD2 Taq1B 231 
polymorphism had an influence on abstinence motivation in smokers (Stages of change scale; 232 
see Table 1): Smokers homozygous for the B2 allele indicated that they had made twice as 233 
many quit attempts in the last 12 months than smokers with the B1 allele (MB2smokers = 1.9, SD 234 
= 1.4; MB1smokers = 1, SD = 1.3; F(1, 82) = 8.82,  pcorrected = .02, η² = .1). 235 
 236 
4. Discussion 237 
The present study sought to determine the role of the DRD2 Taq1B polymorphism on 238 
approach-avoidance biases toward smoking-related and natural-reward stimuli in smokers and 239 
non-smokers. To this end, we reanalyzed data from our recent study [10] to examine the 240 
contribution of the DRD2 gene on approach-avoidance tendencies in smokers and non-smokers.  241 
While we did not find a genotype-mediated difference in approach-avoidance behavior 242 
in the entire sample, we found genotype x smoking status interactions with respect to specific 243 
approach biases towards smoking-related relative to natural-reward related stimuli. In 244 
particular, smokers carrying the B1 allele showed a reduced approach behavior for natural 245 
rewarding (food) stimuli compared to non-smokers with the same allele. The DRD2 Taq1B 246 
polymorphism, however, did not influence responsivity toward different picture categories in 247 
the AAT in non-smokers. Interestingly, in the group of smokers, a higher responsivity toward 248 
smoking-related relative to food-related pictures in the AAT was found in carriers of the B1 249 
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allele. Such a pattern was not found in smokers homozygous for the B2 allele. This pattern of 250 
findings suggests that the B1 allele in combination with smoking behavior is associated with a 251 
decreased sensitivity to naturally-rewarding stimuli (i.e., pictures of highly palatable food).  252 
Furthermore, as an important addition to previous results [10] that indicated a shift in approach-253 
bias toward smoking-related stimuli relative to natural-reward stimuli, we found that this shift 254 
was limited to smokers with the B1 allele. Our findings are indicative of a genetic contribution 255 
to individual variability in approach-avoidance behavior towards naturally-rewarding and 256 
smoking-related stimuli in smokers similar to previous findings in hazardous drinkers [6].   257 
Several previous studies confirmed a close relation between polymorphisms in the 258 
DRD2 gene and tobacco addiction. In this instance, both the B1 allele of the Taq1B 259 
polymorphism of the DRD2 gene and the minor A1 allele of the adjacent ankyrin repeat and 260 
kinase domain containing 1 (ANKK1) gene are found in higher frequency among polysubstance 261 
abusers [39, 40], cocaine-dependent subjects [41, 42] and smokers relative to non-smokers [24]. 262 
A reduced density of dopamine receptors has been reported for both, the minor A1 allele of the 263 
ANKK1 gene and the minor B1 allele of the DRD2 gene [23]. Reduced DRD2 availability has 264 
been linked to the reward deficiency syndrome [43] which is characterized by an increased 265 
likelihood to develop impulsive or addictive behaviors [21], but also to more difficulties to 266 
abstain from addictive behavior. Here we add new data suggesting that differences in approach-267 
avoidance tendencies might contribute to these previous findings regarding the relationship 268 
between DRD2 availability and nicotine addiction.  269 
Previous imaging studies have already suggested an increased threshold for activation 270 
of reward circuits in response to monetary [17] or food reward in tobacco smokers [18]. Our 271 
results indicate that such altered responsivity to natural rewards can also be detected on the 272 
behavioral level (by means of the AAT) which, however, is related to individual differences in 273 
DRD2 availability. A reduced sensitivity to food-related pictures was only found in smokers 274 
carrying the B1 allele which is associated with lower DRD2 availability. Similar to other drugs, 275 
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chronic tobacco use leads to a dysregulation of dopaminergic neurotransmission in meso-276 
corticolimbic areas [15]. These include increases in dopamine cellular activity after acute 277 
tobacco consumption, but also a downregulation of dopaminergic activity in response to natural 278 
reinforcers [15]. Neuroimaging studies [44] suggest that the orbitofrontal cortex is a central 279 
structure responsible for an increased salience attribution to drug cues at the expense of natural 280 
rewards in the course of addictions. Interestingly, reductions in DRD2 go along with decreased 281 
metabolism in prefrontal cortical regions [45]. Thus, in smokers a reduction in DRD2 density 282 
in combination with a decreased prefrontal activity might lead to an aberrant salience attribution 283 
toward drug cues versus food cues representing an important neuroadaptive change in the 284 
mesolimbic dopaminergic function [15]. However, our findings only partially support this 285 
conclusion since smokers with the B1 allele did not show a reduced responsivity (approach 286 
tendency) towards smoking-related cues. This might be due to the fact that we used a sample 287 
of moderate smokers with a mean FTND score of 3.4. Since the AAT is a measure of impulsive 288 
tendencies and the prefrontal cortex has been linked to impulse control [2], a disruption of 289 
prefrontal control due to reduced DRD2 availability might lead to a greater imbalance between 290 
executive and impulsive instances in heavy smokers only [1]. This, in turn could lead to a more 291 
pronounced approach-bias toward smoking cues compared to other cues. Indeed, evidence from 292 
animal and human data suggests a strong negative association between DRD2 availability and 293 
control of impulsivity [46]. Future studies combining AAT and imaging techniques [47] in 294 
heavy smokers genotyped for the Taq1B polymorphism of the DRD2 gene could be helpful to 295 
get more insight into the possible neuronal underpinnings. 296 
A major limitation of the current study is the small sample size which might have limited 297 
the power to detect overall group differences. In particular the smoking status x DRD2 genotype 298 
x picture category approached borderline statistical significance (p=0.053). According to 299 
discriminatory power analyses which we conducted a posteriori, power was sufficient for 300 
detecting main effects and two-way interactions (1-ß > .80), however, the power to detect a 301 
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three-way interaction was indeed very small (1-ß = .65). Thus, the current findings can be 302 
considered as promising, but tentative, and in need of replication with a larger sample. 303 
Furthermore, it would be valuable to investigate the contribution of other dopaminergic 304 
pathway genes on complex smoking behavior phenotypes since it is likely that a single-305 
nucleotide polymorphism has only small effects on smoking.  306 
Nevertheless, our results may have implications for the development of more optimized 307 
smoking cessation interventions. For instance, specific training programs based on the AAT 308 
have been successfully employed to change maladaptive approach biases and to enhance 309 
efficacy of psychological cessation interventions in smokers [48, 49]. However, not all 310 
participants profit equally well from these interventions and a large proportion of ex-smokers 311 
experience relapse phenomena after successful treatment [30] (see: [50] for a review). The basic 312 
rationale of AAT modification paradigms is to incorporate nicotine-related cues as a category 313 
of stimuli to be avoided while cues corresponding to natural rewards such as palatable food or 314 
pictures of pleasant activities should be approached. Thus, in AAT re-training studies for 315 
smokers, participants could be trained to abolish approach behavior towards nicotine stimuli, 316 
but could concomitantly be provided with an alternative behavior, i.e., approaching naturally-317 
rewarding stimuli, or stimuli which are at least less toxic or detrimental. Hence, from a 318 
theoretical perspective, training to approach naturally-rewarding stimuli is equally important as 319 
training to avoid smoking stimuli. Understanding the genetic/biological basis of these 320 
respective approach biases in smokers (vs. non-smokers) is therefore of high interest. Based on 321 
the findings from the present study, it could be concluded that AAT training programs which 322 
aim to increase tendencies to approach naturally-rewarding stimuli (as an alternative category 323 
to smoking-related stimuli) in smokers would be less efficient in B1 allele carriers or that a 324 
more extensive retraining protocol would be needed for those participants. However, it remains 325 
to be determined whether this would also be  associated with a less efficient treatment outcome 326 
in smokers carrying the B1 allele relative to those homozygous for the B2 allele. Nevertheless, 327 
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we found that smokers with the B1 allele underwent fewer attempts to quit smoking compared 328 
to smokers homozygous for the B2 allele which indeed suggests a more persistent course of 329 
smoking behavior. The latter finding corroborates existing literature showing a negative 330 
influence of the B1 allele of the Taq1B polymorphism on smoking severity and the ability to 331 
abstain from smoking [29, 30].  332 
In conclusion, our results indicate a reduced natural-reward brain reactivity in smokers 333 
with the B1 allele of the DRD2 Taq1B polymorphism as evidenced with the AAT. Such a 334 
genetically determined decrease in dopaminergic activity (i.e., reduction of DRD2 availability) 335 
might result in a different outcome after psychological cessation interventions in smokers [48], 336 
which however needs to be explored in future research. 337 
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Fig 1 Approach and avoidance tendencies for each of the genotypes: AAT-Bias Scores were 501 
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